You Li

2.6k total citations
27 papers, 669 citations indexed

About

You Li is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, You Li has authored 27 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in You Li's work include Cancer Risks and Factors (2 papers), COVID-19 Clinical Research Studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). You Li is often cited by papers focused on Cancer Risks and Factors (2 papers), COVID-19 Clinical Research Studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). You Li collaborates with scholars based in China and United States. You Li's co-authors include Deshi Shi, Dongfang Yang, Chris Black, Bingfang Yan, Jian Yang, Edward L. LeCluyse, Fatemeh Akhlaghi, Mohamed I. Elsaid, Carolyn Catalano and Carlos D. Minacapelli and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

You Li

25 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
You Li China 12 235 156 133 117 87 27 669
Hui Xiao China 14 370 1.6× 341 2.2× 75 0.6× 202 1.7× 40 0.5× 42 1.3k
Jaeseong Oh South Korea 15 194 0.8× 64 0.4× 88 0.7× 99 0.8× 70 0.8× 84 723
Vanessa González-Covarrubias Mexico 15 470 2.0× 102 0.7× 47 0.4× 134 1.1× 74 0.9× 43 1.0k
Kenneth Kulmatycki United States 15 247 1.1× 87 0.6× 84 0.6× 99 0.8× 84 1.0× 39 899
Hany Akeel Al-Hussaniy Iraq 16 192 0.8× 59 0.4× 65 0.5× 104 0.9× 36 0.4× 49 767
Mitsuhiro Goda Japan 18 198 0.8× 60 0.4× 74 0.6× 205 1.8× 28 0.3× 94 909
Sven‐Christian Pawelzik Sweden 18 254 1.1× 98 0.6× 336 2.5× 72 0.6× 42 0.5× 26 954
Fangfang Liu China 19 381 1.6× 75 0.5× 95 0.7× 167 1.4× 37 0.4× 46 893
David Han United States 13 102 0.4× 150 1.0× 104 0.8× 54 0.5× 35 0.4× 28 557
Takuro Niwa Japan 11 219 0.9× 87 0.6× 66 0.5× 436 3.7× 188 2.2× 16 824

Countries citing papers authored by You Li

Since Specialization
Citations

This map shows the geographic impact of You Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You Li more than expected).

Fields of papers citing papers by You Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by You Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You Li. The network helps show where You Li may publish in the future.

Co-authorship network of co-authors of You Li

This figure shows the co-authorship network connecting the top 25 collaborators of You Li. A scholar is included among the top collaborators of You Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with You Li. You Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, You, et al.. (2024). BACK ANALYSIS AND STABILITY PREDICTION OF SURROUNDING ROCK DURING EXCAVATION OF THE SHUANGJIANGKOU UNDERGROUND POWERHOUSE. Journal of Civil Engineering and Management. 30(3). 264–278. 1 indexed citations
2.
Tait, Christopher, et al.. (2023). Early-Onset Colorectal Cancer: Prevalence, Risk Factors, and Clinical Features Among Commercially Insured Adults in the United States. Cureus. 15(11). e49432–e49432. 1 indexed citations
3.
Fan, Xiaoyan, et al.. (2022). Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma. Frontiers in Genetics. 12. 681809–681809. 5 indexed citations
4.
Rustgi, Vinod K., You Li, Kapil Gupta, et al.. (2021). Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity. Gastroenterology. 161(1). 171–184.e10. 88 indexed citations
5.
Ma, Yongsheng, et al.. (2020). Unveiling the Pharmacological Mechanisms of Eleutheroside E Against Postmenopausal Osteoporosis Through UPLC-Q/TOF-MS-Based Metabolomics. Frontiers in Pharmacology. 11. 1316–1316. 12 indexed citations
6.
Li, You, Lie Yao, Yishen Mao, et al.. (2020). Partial pancreatic tail preserving subtotal pancreatectomy for pancreatic cancer: Improving glycemic control and quality of life without compromising oncological outcomes. World Journal of Gastrointestinal Surgery. 12(12). 491–506. 3 indexed citations
8.
Li, Xin, Wei He, Yang Chen, et al.. (2017). Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist. ACS Omega. 2(12). 9261–9267. 11 indexed citations
9.
Chen, Xiangyuan, Qichao Wu, You Li, et al.. (2016). Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor. European Journal of Pharmacology. 795. 150–159. 53 indexed citations
10.
Tao, Hua, Xu Zhou, Zhou Liu, et al.. (2016). Role of glyoxalase I gene polymorphisms in late-onset epilepsy and drug-resistant epilepsy. Journal of the Neurological Sciences. 363. 200–206. 8 indexed citations
11.
Si, Yang, Ling Liu, Jie Mu, et al.. (2015). A preliminary observation of the adverse effects of phenobarbital among patients with convulsive epilepsy in rural West China. Epilepsy & Behavior. 54. 65–70. 12 indexed citations
12.
Li, You, et al.. (2015). Comparisons of the Efficacy and Safety of Finasteride and Dutasteride for Benign Prostatic Hyperplasia: A Network Meta-Analysis. American Journal of Therapeutics. 24(5). e517–e523. 7 indexed citations
13.
Tian, Xin, Rachel Giese, Richard Francis, et al.. (2013). Increased postoperative respiratory complications in heterotaxy congenital heart disease patients with respiratory ciliary dysfunction. Journal of Thoracic and Cardiovascular Surgery. 147(4). 1291–1298.e2. 53 indexed citations
14.
15.
Cai, Ji-Ping, Jin-Wei Cheng, Xiaoye Ma, et al.. (2012). Lack of association of conjunctival MALT lymphoma with Chlamydiae or Helicobacter pylori in a cohort of Chinese patients. Medical Science Monitor. 18(2). BR84–BR88. 11 indexed citations
16.
Yin, Jie, et al.. (2010). Clinical analysis of diagnosis and treatment of ocular adnexal mucosa-associated lymphoid tissue lymphoma.. Xiandai shengwu yixue jinzhan. 10(22). 4298–4336.
17.
Cheng, Jin-Wei, You Li, & Rui-Li Wei. (2009). Systematic Review of Intraocular Pressure-Lowering Effects of Adjunctive Medications Added to Latanoprost. Ophthalmic Research. 42(2). 99–105. 14 indexed citations
18.
Li, You. (2007). The relationship between serum magnesium level and bone mineral density in postmenopausal Chinese women. Chinese Journal of Osteoporosis. 2 indexed citations
19.
Shi, Deshi, Jian Yang, Dongfang Yang, et al.. (2006). Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1477–1484. 232 indexed citations
20.
Li, You. (2005). Study of Sleep Quality in Patients with Psoriasis. Chinese Journal of Dermatology. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026